Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 18

2.

Antifungal agents for preventing fungal infections in non-neutropenic critically ill and surgical patients: systematic review and meta-analysis of randomized clinical trials.

Playford EG, Webster AC, Sorrell TC, Craig JC.

J Antimicrob Chemother. 2006 Apr;57(4):628-38. Epub 2006 Feb 3. Review.

PMID:
16459344
3.

Fluconazole for antifungal prophylaxis in chemotherapy-induced neutropenia.

Preston SL, Briceland LL.

Am J Health Syst Pharm. 1995 Jan 15;52(2):164-73; quiz 205-6. Review.

PMID:
12879543
4.

Antifungal prophylaxis in cancer patients after chemotherapy or hematopoietic stem-cell transplantation: systematic review and meta-analysis.

Robenshtok E, Gafter-Gvili A, Goldberg E, Weinberger M, Yeshurun M, Leibovici L, Paul M.

J Clin Oncol. 2007 Dec 1;25(34):5471-89. Epub 2007 Oct 1. Review.

PMID:
17909198
5.

Antifungal prophylaxis with itraconazole oral solution in neutropenic patients.

Kibbler CC.

Mycoses. 1999;42 Suppl 2:121-4. Review.

PMID:
10865918
6.

Role of new antifungal agents in prophylaxis of mycoses in high risk patients.

van Burik JA.

Curr Opin Infect Dis. 2005 Dec;18(6):479-83. Review.

PMID:
16258319
7.

Evaluating prophylaxis of invasive fungal infections in patients with haematologic malignancies.

Maertens J.

Eur J Haematol. 2007 Apr;78(4):275-82. Epub 2007 Jan 23. Review.

PMID:
17241370
8.

Fluconazole prophylaxis in high-risk neonates.

Reed BN, Caudle KE, Rogers PD.

Ann Pharmacother. 2010 Jan;44(1):178-84. doi: 10.1345/aph.1M364. Epub 2009 Dec 29. Review.

PMID:
20040701
9.

Evidence-based assessment of primary antifungal prophylaxis in patients with hematologic malignancies.

Cornely OA, Ullmann AJ, Karthaus M.

Blood. 2003 May 1;101(9):3365-72. Epub 2002 Aug 29. Review.

10.

Evidence-based review of antifungal prophylaxis in neutropenic patients with haematological malignancies.

Glasmacher A, Prentice AG.

J Antimicrob Chemother. 2005 Sep;56 Suppl 1:i23-i32. Review.

PMID:
16120631
11.

[Azole antifungal agents in the prevention of fungal infections in neutropenic patients and bone marrow graft recipients].

Lortholary O, Dupont B.

Ann Med Interne (Paris). 1997;148(3):258-67. Review. French.

PMID:
9255336
12.

[Antifungal prophylaxis in neutropenic cancer patients and in allogeneic bone marrow transplantation].

Blau IW, Fauser AA.

Mycoses. 1996;39 Suppl 1:81-6. Review. German.

PMID:
8767276
13.

Chemoprophylaxis of neonatal fungal infections in very low birthweight infants: efficacy and safety of fluconazole and nystatin.

Blyth CC, Barzi F, Hale K, Isaacs D.

J Paediatr Child Health. 2012 Sep;48(9):846-51. doi: 10.1111/j.1440-1754.2012.02543.x. Review.

PMID:
22970680
15.
16.

Antifungal prophylaxis in bone marrow transplant.

Lam HH, Althaus BL.

Ann Pharmacother. 1995 Sep;29(9):921-4. Review.

PMID:
8547742
17.

[Preventive antimycotic therapy of neutropenic and immunosuppressed patients].

Ruhnke M, Beyer J.

Med Klin (Munich). 1997 Jan 15;92(1):28-36. Review. German.

PMID:
9121412
18.

[Prophylaxis and treatment for invasive fungal infection: update].

Fukuda T.

Rinsho Ketsueki. 2013 Oct;54(10):1932-9. Review. Japanese. No abstract available.

PMID:
24064846

Supplemental Content

Support Center